Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial.

Authors :: Yeni P
Cooper DA
Aboulker J
Babiker AG
Carey D
Darbyshire JH
Floridia M
Girard P
Goodall RL
Hooker MH
Mijch A
Meiffredy V
Salzberger B
INITIO Trial International Co-ordinating Committee
Source :: Lancet. 7/22/2006, Vol. 368 Issue 9532, p287-298. 12p.
Publication Year :: 2006

Full Text Access

Tools